Association of Pepsin With Inflammatory Signaling and Effusion Viscosity in Pediatric Otitis Media

Tina L Samuels1, Pawjai Khampang1, Mana Espahbodi1

  • 1Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, U.S.A.

The Laryngoscope
|July 17, 2021
PubMed
Abstract

Insights

Pepsin in middle ear fluid correlates with effusion viscosity and inflammation in otitis media (OM). This enzyme may worsen OM outcomes, even at neutral pH.

Area of Science:

  • Otolaryngology
  • Pediatric Medicine
  • Gastroenterology

Background:

  • Otitis media (OM) involves inflammation and viscous middle ear effusions, potentially causing hearing loss.
  • Extraesophageal reflux (EER), particularly pepsin, is linked to respiratory inflammation and OM.
  • Understanding pepsin's role in OM is crucial for managing persistent middle ear effusions.

Purpose of the Study:

  • To investigate the association between pepsin and inflammatory signaling in middle ear effusions (MEF).
  • To examine the impact of pepsin on OM outcomes.
  • To evaluate the causal role of pepsin in vitro.

Main Methods:

  • Collected MEF and audiometric data from 30 pediatric patients with recurrent OM.
  • Assayed MEF for pepsin, inflammatory molecules, and mucin using ELISA.
  • Exposed primary middle ear epithelial cultures to pepsin in vitro and measured cytokine expression via qPCR.

Main Results:

  • Pepsin was detected in 77% of MEF samples and correlated with effusion viscosity, IL-6, IL-8, neutrophil elastase, and Mucin 5B.
  • Pepsin-negative MEF showed less frequent presence of IL-8 or Mucin 5B.
  • In vitro, pepsin induced IL-6, IL-8, and TNF at neutral pH, with weak acid facilitating response at lower pepsin concentrations.

Conclusions:

  • Pepsin may contribute to the inflammatory signaling observed in otitis media.
  • The presence of pepsin is associated with increased effusion viscosity and inflammatory markers.
  • Pepsin could play a role in the development of persistent, viscous middle ear effusions and poorer OM outcomes.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
821
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
350
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
698
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.1K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
746
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
6.2K